Why Payer Medical Policy Matters
Behind almost every “approved” or “denied” is a document most patients never see: the payer’s medical policy. For anyone working in market access, reimbursement, or product development, these documents are the difference between a therapy reaching a patient and one stuck at the claims desk. As policy grows more complex and changes faster, understanding how it works and how to keep up with it has never been more important.
What Payer Medical Policy Actually Is
Medical policy is the set of criteria a health plan uses to decide whether a specific procedure, drug, device, or diagnostic is medically necessary and therefore payable.
It’s easy to confuse with the benefit plan, but they operate on different levels. The benefit plan says what categories of care are covered at all. Medical policy sits one level down: given that a benefit exists, does this service, for this patient, meet the plan’s clinical criteria? It spells out the conditions, required documentation, prior authorization rules, and utilization limits.
How Policy Gets Developed
Most payers run a medical policy or technology assessment committee, which typically includes internal medical directors and policy analysts, sometimes supported by external specialists. Their job is to research and weigh the evidence and translate it into coverage criteria.
The inputs are familiar: peer-reviewed literature, health technology assessments, specialty society guidelines, FDA labeling, and systematic reviews. A draft policy is written, sometimes circulated for comment, approved, and then revisited on a schedule (usually annual) or whenever new evidence lands. CMS national and local coverage determinations sometimes anchor commercial policy, so a shift at the federal level can ripple across private plans.
What Actually Influences Policy
Evidence quantity and quality is the headline, but it’s never the whole story. Real-world policy is shaped by the strength and consistency of clinical data, FDA status, specialty guidelines, cost and budget impact, and key opinion leader advocacy. It can also be shaped by what other payers are doing, by utilization and appeals data, and by advocacy from patient groups.
The takeaway: medical policy is shaped by many moving targets. The key for innovative medical technology companies is to determine and push on the levers it can actually control.
Patient Access as a Key Lever in a Non-Coverage Policy Environment
When a procedure or service falls under non-coverage policies, the friction is real: denials, appeals, peer-to-peer reviews, care delays, and out-of-pocket exposure for patients. For manufacturers and providers, it means building the case one claim at a time.
This is where patient access programs earn their keep. Benefits investigations, prior authorization and appeals support fight for access case by case until the coverage landscape catches up. Just as important, that access work generates real-world utilization and outcomes data – the very evidence future policy is built on. Access isn’t only triage for today’s denials; it’s how you build the record that changes the policy tomorrow.
The Good and the Bad of Silent/No Policy
A “silent” policy is the absence of a published position – the payer simply hasn’t addressed the service. It cuts both ways.
The upside is freedom. There are no written restrictions to fight, room to make the case on individual medical necessity, and a genuine chance to influence the policy criteria. With strong documentation, claims can often move through on a case-by-case basis.
The downside is unpredictability. Silence breeds inconsistency: decisions vary by reviewer, by region, and by day. There is no published criteria to work from, making the open space hard to plan around.
Three Key Tools
For innovative medtech companies, having control of the following levers is imperative to influencing medical policy:
Tracking: Restrictive, favorable, or silent, one thing stays constant – policy changes. Working with a tool that can help you track medical policy is essential. (Stay tuned for an exciting announcement from JDL Access about this!)
- Payer Advocacy: Ensuring that payers have the key publications, especially prior to any major policy updates, requires knowing who to contact, when to send the information, and how it should be presented. This can be accomplished by hiring internal, experienced payer access staff or by outsourcing this to a company like JDL Access.
- Patient Access: Fighting for patient access case by case, as discussed, is the important tool available to ultimately influence medical policy. Again, this can be accomplished by hiring internal patient access staff or by outsourcing this to a company like JDL Access.
